IPCA Labs, Paytm Surge in Nifty Midcap 150 RallyStrong Performances Drive Midcap Gains, Ipca Labs Reports Robust Financial GrowthDuring Thursday’s trading session, several stocks posted significant gains, with Ipca Labs and One 97 Paytm leading the Nifty Midcap 150 index. By 2:30 pm, Ipca Labs traded at Rs 1,529.50, up 4.77%, while One 97 Paytm reached Rs 1,113.45, gaining 3.95%. Other notable performers included Coromandel International, Indian Bank, and Fortis Healthcare, reflecting strong momentum in the midcap sector.
Recommended Read: Bajaj Finance Reports Strong Q1FY26 Results
Ipca Labs has shown steady financial growth across recent quarters. For the quarter ending March 2025, consolidated revenue reached Rs 2,246.69 Crore, up from Rs 2,033.01 Crore in March 2024. However, net profit for the same period dipped to Rs 65.78 Crore from Rs 72.91 Crore the previous year. The EPS increased to Rs 2.67 from Rs 2.35 in March 2024.
On an annual basis, Ipca Labs reported consolidated revenue of Rs 8,939.59 Crore in 2025, a significant rise from Rs 7,705.04 Crore in 2024. Net profit grew from Rs 529.21 Crore in 2024 to Rs 787.53 Crore in 2025, with EPS climbing from Rs 25.82 to Rs 35.14 over the same period.
Click here to explore other:
Rupee Extends Slide to Fresh All-Time Low as Trade Tensions and Importer Demand Intensify The…
Sensex Climbs 450 Points, Nifty Ends Near 26,050 as Global Cues Lift Market Sentiment Index…
Edelweiss Mutual Fund Announces First International Retail Offering Through GIFT City Platform Edelweiss Mutual Fund…
Cabinet Meets to Consider Major Policy Overhaul Including Census 2027 and Key Sectoral Reforms The…
Novo Nordisk Brings Ozempic to India at Competitive Weekly Price to Expand Diabetes Treatment Access…
ICICI Prudential AMC IPO GMP Rises as Investor Interest Builds Through the Session The grey…
This website uses cookies.